abstract
Future of Health Summit 2024

Global Collaboration to Eradicate Women’s Cancers

-

The top three women’s cancers globally—breast, cervical and endometrial—affect almost 3.5 million people each year with over 1 million women dying from these diseases. Breast cancer is the most common, affecting 2.29 million women globally. Cervical cancer, on the rise in many parts of the world, disproportionately affects middle- and low- income countries—in sub-Saharan Africa, it surpasses both lung and colorectal cancer as the second most common type after breast cancer. Proven prevention and cancer control approaches can help reduce the burden of these cancers on women, their families, and communities. This panel of global experts will explore strategies to reduce the incidence and mortality of cancers that uniquely affect women, such as expanded access to vaccines, innovative screening technologies, workforce education, and health policy changes. They will share opportunities for collaboration among the public, private, and nonprofit sectors to implement sustainable and equitable cancer care tailored to local needs and resources to improve women's lives worldwide. 

    Moderator

    Image

    Alice Park

    Senior Health Correspondent, TIME

    Speakers

    Image

    Usman Malami Aliyu

    Director General, National Institute for Cancer Research and Treatment, Federal Republic of Nigeria
    Image

    Danielle Carnival

    Deputy Assistant to the President for the Cancer Moonshot; Deputy Director for Health Outcomes, Office of Science and Technology Policy, The White House
    Image

    Dave Fredrickson

    Executive Vice President, Oncology Hematology Business, AstraZeneca
    Image

    Roberta Lipson

    Founder, United Family Healthcare; Vice Chair, New Frontier Health
    Image

    Gemma Peters

    CEO, Macmillan Cancer Support